58 related articles for article (PubMed ID: 8587850)
1. [MR imaging of colonic cancer with retrograde administration of contrast material containing ferric ammonium citrate].
Mizuguchi M; Matsuo Y; Fukahori T; Kudo S
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Dec; 55(15):1063-5. PubMed ID: 8587850
[TBL] [Abstract][Full Text] [Related]
2. [The use of high concentration ferric ammonium citrate (FAC) solution as a negative bowel contrast agent: application in MR cholangiography].
Takahara T; Saeki M; Nosaka S; Shimoyamada K; Suemitsu I; Nakajima Y; Yoshikawa T; Ishikawa T
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Aug; 55(9):697-9. PubMed ID: 7478957
[TBL] [Abstract][Full Text] [Related]
3. [Oral ferric ammonium citrate solution in MRCP for diagnosing low-level obstructive jaundice].
Yang P; Zhang YD; Li NF; Li WZ; Zhou GF
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):347-50. PubMed ID: 17478951
[TBL] [Abstract][Full Text] [Related]
4. [New development of cellulose-ferric ammonium citrate solution as a contrast-enhancement agent for magnetic resonance imaging of esophageal diseases].
Ogawa Y; Noda Y; Sawada A; Fujiwara Y; Hamada N; Terashima M; Inomata T; Yoshida S; Morio K
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Oct; 54(12):1178-80. PubMed ID: 9261198
[TBL] [Abstract][Full Text] [Related]
5. Positive bowel contrast agent for MR imaging of the abdomen: phase II and III clinical trials.
Patten RM; Lo SK; Phillips JJ; Bowman SC; Glazer GM; Wall SD; Bova JG; Harris RD; Wheat RL; Johnson CD
Radiology; 1993 Oct; 189(1):277-83. PubMed ID: 8372205
[TBL] [Abstract][Full Text] [Related]
6. [High concentration ferric ammonium citrate (FAC) solution as a negative bowel contrast agent].
Takahara T; Yoshikawa T; Saeki M; Nosaka S; Shimoyamada K; Nakajima Y; Ishikawa T
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 May; 55(6):425-6. PubMed ID: 7617470
[TBL] [Abstract][Full Text] [Related]
7. [MR imaging oral contrast agent mixed with milk for the small intestine].
Hirohashi S; Hirohashi R; Uchida H; Kitano S; Tanaka M; Matsuo N; Ohishi H
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Jul; 54(8):784-8. PubMed ID: 8072869
[TBL] [Abstract][Full Text] [Related]
8. [Benign hepatic tumors: MRI features before and after administration of superparamagnetic contrast media].
Bartolotta TV; Midiri M; Galia M; Carcione A; De Maria M; Lagalla R
Radiol Med; 2001 Apr; 101(4):219-29. PubMed ID: 11398050
[TBL] [Abstract][Full Text] [Related]
9. [Clinical efficacy of suppression and visualization of the duodenal fluid in MR cholangiopancreatography using ferric ammonium citrate].
Takahara T; Kurihara Y; Takahashi M; Nakajima Y; Ishikawa T
Nihon Rinsho; 1998 Nov; 56(11):2865-9. PubMed ID: 9847611
[TBL] [Abstract][Full Text] [Related]
10. [Nuclear magnetic resonance tomography of the pelvis: rectal administration of a new super-paramagnetic contrast medium].
Kersting-Sommerhoff B; Allgayer B; Western A; Gerhardt P
Rontgenpraxis; 1995 Dec; 48(12):353-6. PubMed ID: 8584960
[No Abstract] [Full Text] [Related]
11. Gastrointestinal contrast agents for MR imaging.
Brown JJ
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):25-35. PubMed ID: 8673714
[TBL] [Abstract][Full Text] [Related]
12. MR imaging of the pancreas at 0.3 T using a super-paramagnetic oral contrast medium.
Wallengren NO; Holtås S; Andrén-Sandberg A; Bach-Gansmo T
Acta Radiol; 1994 Mar; 35(2):147-51. PubMed ID: 8172740
[TBL] [Abstract][Full Text] [Related]
13. Ferric ammonium citrate as a positive bowel contrast agent for MR imaging of the upper abdomen. Safety and diagnostic efficacy.
Kivelitz D; Gehl HB; Heuck A; Krahe T; Taupitz M; Lodemann KP; Hamm B
Acta Radiol; 1999 Jul; 40(4):429-35. PubMed ID: 10394873
[TBL] [Abstract][Full Text] [Related]
14. [Optimization of dosage and exam technique in the use of oral contrast media in magnetic resonance].
Broglia L; Tortora A; Maccioni F; Arpesani R; Marcelli G; Ascarelli A; Rossi P
Radiol Med; 1999 May; 97(5):365-70. PubMed ID: 10432968
[TBL] [Abstract][Full Text] [Related]
15. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
[TBL] [Abstract][Full Text] [Related]
16. Detection of colonic masses with MR colonography.
Haykir R; Karaköse S; Karabacakoğlu A; Kayaçetin E; Sahin M
Turk J Gastroenterol; 2006 Sep; 17(3):191-7. PubMed ID: 16941252
[TBL] [Abstract][Full Text] [Related]
17. [Effects of biphasic spiral CT, conventional and iron oxide enhanced MRI on therapy and therapy costs in patients with focal liver lesions].
Helmberger T; Gregor M; Holzknecht N; Rau H; Scheidler J; Reiser M
Rofo; 2000 Mar; 172(3):251-9. PubMed ID: 10778456
[TBL] [Abstract][Full Text] [Related]
18. [Magnetic resonance tomography of focal liver and spleen lesions. Experiences using ferrite, a new RES-specific MR contrast medium].
Rummeny E; Weissleder R; Stark DD; Elizondo G; Ferrucci JT
Radiologe; 1988 Aug; 28(8):380-6. PubMed ID: 3174975
[TBL] [Abstract][Full Text] [Related]
19. Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization.
Kubaska S; Sahani DV; Saini S; Hahn PF; Halpern E
Clin Radiol; 2001 May; 56(5):410-5. PubMed ID: 11384141
[TBL] [Abstract][Full Text] [Related]
20. Dark lumen MR-colonography: initial experience.
Lauenstein TC; Herborn CU; Vogt FM; Göhde SC; Debatin JF; Ruehm SG
Rofo; 2001 Sep; 173(9):785-9. PubMed ID: 11582556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
